Lucia +
a 501(c)(3) dedicated to Lucia N°03 US R+D
what we want
objective.
To elevate human potential by facilitating clinical research using Lucia N°03 + US populations validating our ‘techdelic’ as an effective substance-free psychedelic alternative.
Increase Education
Promote education (+destigmatization) of psychedelic science & psycholysis via our effective, safe, legal experience
Increase Safety & Harm Reduction
Ethical practitioner training, patient screening, preparation & integration tool, featuring responsible data collection, rooted in patient advocacy vs. profit driven collaborations
Increase Accessibility
Promote accessibility via wider spectrum of psychedelic therapy services utilizing Lucia N°03 & attain insurance reimbursement as validated psycholysis alternative
501(c)(3) purpose:
conduct necessary clinical research & validation studies using Lucia N°03 + US populations.
lucia + research
Conducting clinical grade research using US populations, replicating our globally validated existing research
lucia + sensitive target populations
Validate our use for sensitive populations, and provide access to our technology for those who need safe, effective holistic opportunities most
lucia + quantified self revolution
Personalized data to inform a customized protocol, maximize therapeutic outcomes, and support client autonomy.
what we solve.
scientific validation for systemic impact.
- facilitate clinical research using Lucia N°03 + US populations
- replicate global research validating our technology as a substance-free psychedelic alternative
- validate our ‘techdelic’ as an effective substance-free ‘techdelic’
- establish Lucia N°03 within infrastructure of psychedelic research and therapy
- widen spectrum of patients who can receive a validated effective treatment alternative
what we need
milestones.
steps to transform our vision into reality: it all starts with proving efficacy & feasibility.
Fund Studies
Fund feasibility studies to validate efficacy of our technology as a non-pharmacological psychedelic alternative.
Conduct Studies
Conduct feasibility studies demonstrating efficacy on target populations.
Implement Technology
Establish Lucia N°03 within infrastructure of psychedelic research and therapy.
Lucia N°03 + psychedelic research
psychedelic research applications.
opportunities for Lucia N°03 to serve as a scientifically validated ‘techdelic.’
- use as ‘active placebo’ in psychedelic research
- use mirrored protocol to expand ongoing psychedelic Research & optimize Protocols/therapeutic Outcomes
- increase roi/ decrease investment exploring significant variables
- conduct remote research & inform ongoing scientific data collection using clinical-grade wearable technology
Lucia N°03 + safety & harm reduction
responsible implementation of psychedelic therapy.
opportunities for Lucia N°03 to serve as a scientifically validated ‘techdelic.’
- safe, non-invasive, Substance-Free Experience
- therapist training, continued education, & respite
- Medical-Grade Screening Tool for Safety & Harm Reduction
- Preparation & Integration of ‘peak EXPERIENCES’ (substance or substance-free)
Lucia N°03 + scaling psychedelic therapy
sustainable expansion of psychedelic therapy.
opportunities for Lucia N°03 to serve as a scientifically validated ‘techdelic.’
scalability
- practitioner training
- increase safe, effective practitioner training opportunity while decreasing time necessary to induce (non-pharmacological) altered state
- local and global ‘pollinators’ of psychedelic science education, substance-free experiences, and support
- expanding necessary support structure for preparation/integration of experiences (with psycholysis treatment team or our light community)
- provide remote experiences for those without access to psycholysis
accessibility
- targeting sensitive populations for research participation to create opportunity for accessibility and biodiversity (leading to greater destigmatization)
- provide remote experiences in response to covid-19
- insurance reimbursement as validated non-pharmacological alternative to psycholysis
- integrate with existing mental health and holistic wellness applications to serve new holistic health paradigm
lucia + covid-19
On-site and remote clinical grade opportunities, prioritizing service opportunities for frontline workers.
- Mental Health & Wellness Programs (Employer/ Remote/ On-site)
- On-site Covid-safe ‘Containers’
- Services for Frontline Workers & Hospitals
- Conduct Research Exploring Our Technology for Effective Post-Infection Recovery
- Quarantine, SAD, + Lucia N°03
mission.
our why
- replicate our globally validated research using sensitive US target populations
- safely & effectively serve the broadest spectrum of clients as a substance-free ‘techdelic’
- inform clinical research
- create intentional biodiversity and accessibility opportunities for underserved and suffering populations
- increase patient & practitioner biodiversity
- increase de-stigmatization
- become a validated tool to
- safely scale psycholysis
- effectively serve the demand for effective, non-invasive modalities to serve mental health & holistic wellbeing
- support a new holistic medical paradigm, informing personalized protocol with wearable technology
- gather ethical and significant data to inform clinical research & maximize personal therapeutic efficacy
- correlate personalized trends by tracking personalized variables
- patient advocacy vs. profit driven collaborations
- ethical practitioner training
- ethical data collection
- ethical practitioner & patient education
- patient/research tool:
- active ‘placebo’ for psychedelic research
- screening
- preparation
- substance-free experience
- integration
- remote research + experience in response to covid-19
vision.
our goals as a NPO
- complete legal filing
- fund:
- demo light
- wearable pilot study
- feasibility studies
- active MAPS substudy
- collaboration validation studies active within psychedelic & non-psychedelic communities
- unified (global) protocol for on-site(/+remote) clinical application as a substance-free ‘techdelic’
- practitioner training & continued education
- client tool for education/screening/substance-free experience/preparation/integration
- Medicare/Medicaid accessibility as a validated substance-free ‘techdelic’ alternative to psycholysis or ketamine assisted psychoherapy
– Lucia N°03 (US + global) wellness & research centers
- education, preparation & integration services
- substance-free alternative experiences
- informing clinical research for psycholysis training + protocol development
- neurodegenerative & clinical applications
- mental health & wellbeing
- quantifiable systemic change as a tool for safety & harm reduction, adopted by all medical and holistic health communities
- a thriving community of local and global pollinators of (psychedelic & non-psychedelic) education, destigmatization, experience, & ongoing support/integration for a thriving new holistic paradigm.
À la Carte.
individual donations per item
Lucia N°03 Practitioner Model
- $24,800
- 8 led + 1 halogen
- 1-6 users per session
Make a donation to purchase a practitioner model lamp for demonstration purposes. Your donation allows us to send our practitioner model light to prospective collaborators, illuminating them to the full power of our technology.
Lucia N°03 Home Portal
- $8,450
- 4 led + 1 halogen
- 1 user per session
Make a donation to purchase a home portal lamp for demonstration purposes. Purchasing a home portal will allow us to send this model to prospective collaborators – specifically showcasing the potential for remote research and experiences.
wearable pilot study personal hardware
- $8,900
- muse eeg headband
- biostrap hrv strap
- muse eeg headband: $350
- biostrap: $100
- home portal: $8,450
Make a donation to fund a full remote setup for demonstration purposes: including eeg + hrv clinical grade wearables + our home portal. This donation will allow us to demonstrate with potential collaborators how we may conduct remote research – especially important in response to covid-19.
Protecting Human Research Participants: Online Training & Certification ($1,000)
Accelerator program: price tbd (est.$2,000)
preserve integrity of our belief in patient vs. profit
Prix Fixe.
fully-funded project package *estimates
Veteran Feasibility Study ($24,200)
FDA approval of psychedelic therapy has been established as a breakthrough treatment for PTSD using MDMA in veteran populations, validating efficacy and justifying further research.
- TOTAL COST: $ 24,200
- n=25
- VA HOME OR CLINIC
- Within SF Bay AREA
- n=25
- (no light purchase)
Accelerator program: price tbd (est.$2,000)
preserve integrity of our belief in patient vs. profit
We can implement our home portal in combination with complimentary wearable technologies, to conduct remote clinical grade research, optimizing and reducing cost of psychedelic clinical research.
- n=25
- ($450×25 = $11,250 hardware)
- muse eeg headband: $350
- biostrap: $100
- biostrap lab platform : $20,000
- fees & expenses: $250
- $31,500 total
Remote Ketamine Feasibility Study ($45,700)
The only legal form of psychedelic therapy available currently in US are ketamine clinics, providing access to ‘real world’ population (in clinics and via remote therapy) to conduct research and validate our technology as a substance-free alternative.
Ketamine remote feasibility study
- n=25
- Home portal purchase
- incentive: each participant keeps wearables
- TOTAL COST: $ 45,700
collaborations.
aligned missions serve symbiotic puropose
- serving US veterans
- practitioner traingng
- suuce-fr
- the Monroe Institute
- 40 years of Zen
– frontline workers / PTSD trials as ‘active placebo’
Common Questions
Let's get in touch
Email Address
jessica@lucidholistics.com
Call Us
1.707.492.7599